Updated
Updated · The Guardian · Aug 17
Trump Administration Cancels $15 Million in Alzheimer's Grants at Emory, Pittsburgh Over DEI
Updated
Updated · The Guardian · Aug 17

Trump Administration Cancels $15 Million in Alzheimer's Grants at Emory, Pittsburgh Over DEI

1 articles · Updated · The Guardian · Aug 17

Summary

  • $15 million in NIH funding for at least three Alzheimer's and brain-health grants at Emory University and the University of Pittsburgh was canceled by late July after funds had resumed in June.
  • The administration said the projects no longer matched NIH priorities, objecting to survey-based and self-reported measures tied to discrimination and racism rather than disputing the underlying disease focus.
  • Researchers said the cuts hit studies on how divestment, discrimination and other socially driven risks shape dementia, after months of delayed payments had already forced some teams to operate on a shoestring.
  • The cancellations extend Trump's broader purge of perceived DEI-linked science from the NIH's $47 billion portfolio, but these grants fall outside earlier litigation over $783 million in NIH cuts that the Supreme Court let proceed.

Insights

Why did the NIH abruptly cancel $15 million in Alzheimer's research just a month after renewing the grants?
What happens to high-risk Alzheimer's patients when studies on their specific environmental risk factors are suddenly halted?
How will the rejection of standard health surveys redefine the future of neurological research and dementia treatments?